匹多莫德辅助治疗小儿支气管哮喘的临床疗效探讨
2017-10-12王杏芳
王杏芳
DOI:10.16662/j.cnki.1674-0742.2017.23.155
[摘要] 目的 探讨匹多莫德辅助治疗小儿支气管哮喘的临床效果。方法 方便选取2015年6月—2016年6月该院就诊的118例支气管哮喘患儿进行分析,随机分为两组(对照组和观察组),每组59例,对照组患者根据GINA方案进行常规治疗,观察组患者在此基础上联用匹多莫德进行治疗,并比较两组患儿临床效果、治疗后哮喘发作次数、持续时间以及IgG、IgA和IgM等指标变化情况。 结果 与對照组(78.0%)相比,观察组患者临床治疗总有效率(89.8%)显著提高,两者比较差异有统计学意义(P<0.05);治疗后观察组患者哮喘发作次数和持续时间均明显低于对照组,两者比较差异有统计学意义(P<0.05);治疗后,观察组患者IgG、IgA和IgM等指标明显优于对照组,两者比较差异有统计学意义(P<0.05)。 结论 常规治疗基础上辅以匹多莫德有助于提高支气管哮喘患儿临床疗效以及改善其免疫功能,其值得推广借鉴。
[关键词] 支气管哮喘;匹多莫德;辅助治疗;临床效果
[中图分类号] R5 [文献标识码] A [文章编号] 1674-0742(2017)08(b)-0155-03
Clinical Study on the Effect of Pidotimod on the Treatment of Bronchial Asthma in Children
WANG Xing-fang
Department of Pediatric, Lijin No.2 Peoples Hospital, Dongying, Shandong Province, 257400 China
[Abstracts] Objective This paper tries to explore the clinical effect of pidotimod in the treatment of pediatric bronchial asthma. Methods 118 cases of bronchial asthma in children from June 2015 to June 2016 in this hospital were conveniently selected and analyzed and randomly divided into two groups (control group and observation group), each group of 59 cases. Patients in the control group were routinely treated according to the GINA regimen, and patients in the observation group were treated with pidotimod and the clinical effects of the two groups, the number of episodes, the duration of asthma and the changes of IgG, IgA and IgM after treatment were compared. Results The total effective rate was 89.8% in the observation group, significantly higher than that in the control group of 78.0%. The difference between the two groups was statistically significant(P<0.05). After treatment, the number and duration of asthma attacks in the observation group were significantly lower than those in the control group, the difference was statistically significant (P<0.05). After treatment, the levels of IgG, IgA and IgM in the observation group were significantly better than those in the control group, the difference were statistically significant(P<0.05). Conclusion On the basis of routine treatment, the combination of pidotimod can improve the clinical efficacy of children with asthma and improve its immune function, which is worth reference.
[Key words] Bronchial asthma; Pidotimod; Adjuvant therapy; Clinical effect
支气管哮喘是临床上较为常见的一种呼吸系统疾病,由嗜酸性粒细胞和T淋巴细胞参与,该病在儿童人群中多见,发病率在国内约为0.12%~3.34%[1]。临床研究报道,小儿支气管哮喘主要临床症状包括气短、咳嗽、胸闷、喘息,对患者身体健康带来极大威胁,导致患儿生活质量明显减低[2]。临床上治疗小儿支气管哮喘的目的为有效控制临床症状,预防病情反复发作或加重,促进肺功能恢复,减少和避免不良反应的出现,维持机体正常活力以及减少死亡率,而合理选取药物治疗对良好预后具有重要作用。……
